How Fast Wegovy Works — and What to Expect While You Wait

The decision most people are actually making: is it working yet, or should I be worried?

This is the question sitting behind most searches about Wegovy's speed. You have started, or you are about to start, and you want to know whether the absence of dramatic early change is normal or a sign something is wrong. The honest answer is that it is almost always normal.

The first four weeks of treatment use a 0.25mg dose. That dose exists purely for tolerability, to let your body adjust to the medicine without a storm of nausea. You are not expected to see large weight changes at that level. By weeks five to eight the dose moves to 0.5mg, and appetite suppression typically becomes more noticeable. Most people find they are naturally eating less before they have consciously counted a single calorie.

Weight on the scales tends to follow three to six weeks behind what your appetite is doing. Fluid shifts, muscle retention and bowel habits all affect the number, so daily weigh-ins at this stage are more likely to cause anxiety than insight. A weekly reading at the same time, same conditions, gives a clearer picture. If you want to understand how fast Wegovy works across the early weeks of treatment, that page walks through what to expect at each stage of the dose schedule. For more on what the semaglutide research actually shows about early versus late response, the semaglutide timeline explainer covers the mechanism in detail.

What the dose schedule means for your expectations

Wegovy's maintenance pathway moves from 0.25mg through 0.5mg, 1.0mg, 1.7mg and then 2.4mg, each step approximately four weeks apart and each governed by the prescriber rather than by a fixed calendar. Some people tolerate the titration smoothly and reach maintenance dose in around four months. Others stay longer at an intermediate step because of nausea or other gastrointestinal side effects, and that slower climb is clinically sound.

The practical implication is that results are dose-dependent. The trial data (published in the NEJM STEP 1 paper) reflects the full 68-week arc including time at lower and higher doses. Expecting 15% average weight loss by week twelve is not realistic; expecting a clear downward trend by week twelve, with the larger reductions coming through months four to twelve, is.

The timing of orders matters in small, practical ways. If you start in the run-up to a holiday or a busy stretch at work, the gastrointestinal adjustment period lands at the same time as disruption to routine, which can make it harder to assess. It is worth thinking about when you order your first pen and planning a relatively settled few weeks around it. If you want to understand how long before Wegovy typically produces visible results, that page unpacks the distinction between appetite effect and weight effect.

When slower progress deserves a clinical conversation

NICE's appraisal of semaglutide (TA875, published March 2023) includes a specific checkpoint: if a person on the full maintenance dose has not achieved at least 5% weight loss after six months, continuing treatment should be reviewed. That review is a clinical process, not an automatic stop, but it is the formal threshold that prescribers use.

Short of that threshold, there are softer signals worth discussing with a prescriber: no change in appetite despite reaching a higher dose, persistent side effects that are preventing dose increases, or weight that stalled very early and has not budged in several weeks despite adherence. A prescriber can look at whether the dose needs adjusting, whether timing of the injection could be optimised, or whether the diet and activity context is working against the medicine. Our clinical team routinely fields these questions through aftercare, it is not a sign of failure to ask.

Common gastrointestinal side effects (nausea, loose stools, reflux, feeling full very quickly) are well documented by the NHS semaglutide guidance and typically settle as the body adjusts or after a dose increase passes. They do not mean the medicine is not working; they often accompany the period of strongest appetite suppression. If you are weighing up cost alongside this timeline, the Wegovy cost page explains what a realistic monthly outlay covers across a multi-month treatment course.

Setting a fair measure of progress

Weight on a scale is only one measure, and not always the fastest one to move. Clothes fitting differently, blood pressure readings shifting, energy on walks improving, sleep quality changing, these frequently appear before the number on the scale reflects them. They are real and they are clinically relevant.

For most people on Wegovy, the honest six-month view is: meaningfully less appetite from around weeks three to six; visible scale reduction from around weeks eight to twelve; increasingly significant losses through months four to twelve as maintenance doses do their work. The full timeline breakdown maps this out phase by phase if you want more granular detail. If you are further into your journey and feel the pace has stalled, the pace of weight loss on Wegovy page explores why variation between individuals is wider than most clinical summaries suggest.

If you are at the beginning (weighing up whether to start, or wondering which treatment is right for you) the weight-loss treatments overview covers both Wegovy and Mounjaro with the same level of clinical detail. Speak to our prescribers through a free consultation, and a real clinician reviews your answers the same day to determine whether Wegovy is suitable for you.